The George-Huntington-Institute (GHI) located in Münster, Germany is devoted to clinical care and preclinical and clinical research in Huntington’s disease (HD). GHI entertains one of the largest HD out-patient clinics for symptomatic and premanifest gene carriers, persons at-risk and caregivers around the world. GHI offers participation in ENROLL-HD, HD-Clarity and multiple clinical trials aimed at improving therapeutic options for HD.
Involved in the feasibility study as a clinical site representing the HD part of the study. Takes part in:
– Providing clinical insights to the selection technologies
– Design of the COS.
– Integrate views and opinions of patients
– Lead and coordinate the activities of the HD partners in the preparation and conduct of the COS
• Huntington’s disease – 35
• Healthy controls – 35